Sector: MedicalDr. Reddy's Laboratories Ltd (NYSE: RDY)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 193 |
Technical : | 23 |
Performance : | 51 |
Overall: | 44 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 196 |
Technical : | 22 |
Performance : | 56 |
Overall: | 45 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 157 |
Technical : | 191 |
Performance : | 134 |
Overall: | 187 |
Number of Stocks: | 306 |
Headlines
- Model N to offer revenue tool with Sierra Atlantic
Nov 19, 2009 01:28 PM | RDY
- Paediatrics hospital at NICE
Nov 16, 2009 04:56 PM | RDY
- IIM-B opens door to cos for internship
Nov 12, 2009 02:24 PM | C, DIS, GS, MS, RDY
- Dr. Reddy's Laboratories (RDY) Impressive On Both Fundamental And Technical Basis
Nov 09, 2009 01:05 PM | AZN, BUCY, GSK, RDY, TEVA
- Dr. Reddy’s Lab maintains momentum
Nov 08, 2009 04:19 PM | HDB, IBN, INFY, RDY, SAY
- Recovery tempered by challenges
Nov 07, 2009 01:48 PM | ABB, RDY
- Dr. Reddy’s Lab shines amid falling market
Nov 01, 2009 01:24 PM | HDB, IBN, MHP, PTI, RDY, TCL
- Biosimilars will drive growth for Dr Reddy’s, says Chairman
Oct 27, 2009 04:52 PM | MRK, RDY
- Mahindra Satyam tumbles
Oct 25, 2009 02:49 PM | HDB, IBN, INFY, RDY, SAY
- Dr Reddy’s Q2 net surges on revenue growth in generics
Oct 23, 2009 04:27 PM | RDY
- AMRI Announces Third Quarter 2009 Results
Nov 09, 2009 07:52 AM | AMRI, BMY, RDY
- Dr. Reddy's Q2 FY10 Results
Oct 23, 2009 05:53 AM | RDY
- Ceragenix and MEGAPHARM Enter Into Distribution and Supply Agreement for EpiCeram®
Jul 27, 2009 07:52 AM | CGXP, RDY
- Dr. Reddy’s Q1 FY10 Results
Jul 21, 2009 07:44 AM | RDY
- Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F
Jul 08, 2009 04:13 AM | RDY
- Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
Jul 08, 2009 03:17 AM | RDY
- Dr. Reddy’s Announces Strategic Alliance with GSK for Emerging Markets
Jun 15, 2009 09:28 AM | RDY
- Dr. Reddy’s Announces ANDA Approval of Omeprazole Mg OTC
Jun 09, 2009 09:51 AM | RDY
- Dr. Reddy’s Receives Approval for Three INDs and Announces Reorganization of Its Drug Discovery Operations
May 22, 2009 03:10 AM | RDY
- Ceragenix Enters into Second Exclusive Option to License Agreement for Antimicrobial Medical Device
May 11, 2009 07:58 AM | CGXP, RDY
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
RDY
|
Compare to S&P
|
| YTD |
147.14 %
|
104.15 %
|
| 4 Weeks |
18.38 %
|
17.75 %
|
| 12 Weeks |
46.34 %
|
37.33 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: 50.00 %
|
|
Sales Growth in Last Quarter: 0.26 %
|
|
Sales Growth in Last Quarter: 9.77 %
|
|
